NFAM1

Across TCGA pan-cancer cohorts, NFAM1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated NFAM1 data layer compared with 24 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher NFAM1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated NFAM1 expression acts as an unfavorable survival marker.

LUAD and LSCC are the cancer types where NFAM1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.707	1.000	.039	2	view →
LSCC	DFS	Quartile	II,III,IV	0.209	0.747	.031	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

NFAM1–LUAD (OS)

Open the LUAD breakdown →